Arcalyst - 61755-001-01 - (rilonacept)

Alphabetical Index


Drug Information of Arcalyst

Product NDC: 61755-001
Proprietary Name: Arcalyst
Non Proprietary Name: rilonacept
Active Ingredient(s): 160    mg/2mL & nbsp;   rilonacept
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Arcalyst

Product NDC: 61755-001
Labeler Name: Regeneron Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125249
Marketing Category: BLA
Start Marketing Date: 20080227

Package Information of Arcalyst

Package NDC: 61755-001-01
Package Description: 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE

NDC Information of Arcalyst

NDC Code 61755-001-01
Proprietary Name Arcalyst
Package Description 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE
Product NDC 61755-001
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rilonacept
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20080227
Marketing Category Name BLA
Labeler Name Regeneron Pharmaceuticals, Inc.
Substance Name RILONACEPT
Strength Number 160
Strength Unit mg/2mL
Pharmaceutical Classes

Complete Information of Arcalyst


General Information